Edesa Biotech Inc (EDSA) Stock Price, Quote & News

Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic aller...

Industry: Biotechnology

Sector: Healthcare

Phone: 289 800 9600

Website: www.edesabiotech.com

Address:

100 Spy Court, Markham, Canada

Boywithathorn Aug. 10 at 5:49 PM

$EDSA though I still think we do well here. The lying and bs with management is beyond words. How directors allow this bs without lawsuits is insane. Years n years investors are told “exciting” news but then the company just sweeps it under the rug. Just pissed I have to work a real job not a company that does nothing for 3 years. The DEI sweepstakes. https://finance.yahoo.com/sectors/healthcare/articles/edesa-biotech-edsa-reaffirms-2026-141446344.html

0 · Reply

Beowulfdragonslayer Aug. 10 at 2:22 PM

$EDSA back to $1?

1 · Reply

allemi Aug. 10 at 1:47 PM

$EDSA one day, Boom!!! BP partnership. $25 then $50.

0 · Reply

Treb3k Aug. 9 at 9:40 PM

$EDSA https://hadea.ec.europa.eu/calls-tenders/framework-contracts-speed-development-and-access-next-generation-therapeutics-infectious-diseases_en?

0 · Reply

AllmightyDollah Aug. 9 at 7:23 PM

$EDSA $EDSA We will overtake $6. And shortly after $7 close to $8. That’s when things start getting real here with news. There’s a reason most all didn’t sell at $15/20. Just think about it. Velan who owns 30% of the company didn’t sell any stock on pop to $20 and there was plenty volume to do so. Their position at $2 a share and could easily dumped $15-$20 a share in last few months. But held. Do they see $30/40? It makes sense.

0 · Reply

Beowulfdragonslayer Aug. 9 at 6:11 PM

$EDSA is the Indian scammer still scammin?

1 · Reply

topstockalerts Aug. 7 at 10:23 PM

$EDSA the market seems to like this one

1 · Reply

Boywithathorn Aug. 7 at 10:03 PM

$EDSA Interesting birds chirping. 🔥

0 · Reply

JoeDomiano Aug. 7 at 9:41 PM

$EDSA

0 · Reply

History101 Aug. 7 at 4:43 PM

$EDSA I was adding all morning...loving it!!

1 · Reply

Edesa Biotech files to sell 729,241 common shares for holders

2026-06-29T19:50:30.000Z - 5 weeks ago

Edesa Biotech reinstated with a Buy at Brookline

2026-06-11T13:27:38.000Z - 2 months ago

Edesa Biotech announces $3.5M private placement

Jun 11, 2026, 9:15 AM EDT - 2 months ago

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

Jun 5, 2026, 9:20 AM EDT - 2 months ago

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

2026-05-19T13:40:50.000Z - 2 months ago

Edesa Biotech Inc trading resumes

2026-05-19T13:35:48.000Z - 2 months ago

Edesa Biotech Inc trading halted, volatility trading pause

May 19, 2026, 9:15 AM EDT - 2 months ago

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

May 14, 2026, 4:30 PM EDT - 3 months ago

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

2026-04-28T14:26:55.000Z - 3 months ago

Edesa Biotech Inc trading halted, volatility trading pause

2026-04-28T14:20:13.000Z - 3 months ago

Edesa Biotech Inc trading resumes

Mar 31, 2026, 4:20 PM EDT - 4 months ago

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

2026-03-26T13:37:21.000Z - 4 months ago

Edesa Biotech provides update on EB06 clinical study

Mar 26, 2026, 9:15 AM EDT - 4 months ago

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

2026-02-24T14:20:13.000Z - 5 months ago

Edesa Biotech reports additional results from Phase 3 paridiprubart study

Feb 24, 2026, 9:15 AM EST - 5 months ago

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

2026-02-13T21:25:18.000Z - 6 months ago

Edesa Biotech reports Q1 EPS (28c), consensus (45c)

Feb 13, 2026, 4:20 PM EST - 6 months ago

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Dec 12, 2025, 4:20 PM EST - 8 months ago

Edesa Biotech Reports Fiscal Year 2025 Results

Oct 31, 2025, 4:30 PM EDT - 10 months ago

Edesa Biotech Announces Upcoming Conference Schedule

2025-10-28T11:55:48.000Z - 10 months ago

Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint

Oct 28, 2025, 7:45 AM EDT - 10 months ago

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Aug 8, 2025, 4:35 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

2025-07-25T20:50:18.000Z - 1 year ago

Edesa Biotech files $150M mixed securities shelf

2025-06-27T14:35:08.000Z - 1 year ago

Edesa Biotech assumed with a Buy at H.C. Wainwright

2025-05-23T10:55:53.000Z - 1 year ago

Edesa Biotech initiated with a Buy at Lucid Capital

May 14, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

2025-04-04T20:20:09.000Z - 1 year ago

Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO

Apr 4, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Announces Chief Financial Officer Transition

2025-03-04T21:36:26.000Z - 1 year ago

Edesa Biotech files to sell 7.81M common shares for holders

Feb 14, 2025, 4:15 PM EST - 1 year ago

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

2025-02-13T12:55:07.000Z - 1 year ago

Edesa Biotech announces $15M private placement priced at-the-market

Feb 13, 2025, 7:00 AM EST - 1 year ago

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 13, 2024, 4:30 PM EST - 1 year ago

Edesa Biotech Reports Fiscal Year 2024 Results

2024-10-31T12:33:18.000Z - 1 year ago

Edesa Biotech founder Par Nijhawan to invest up to $5M in company

Oct 31, 2024, 8:15 AM EDT - 1 year ago

Edesa Biotech's Founder Makes Strategic Investment in the Company

Sep 13, 2024, 7:38 PM EDT - 2 years ago

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

Aug 9, 2024, 4:20 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Jun 24, 2024, 8:20 AM EDT - 2 years ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

May 10, 2024, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Apr 2, 2024, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Investor Conferences

Mar 21, 2024, 4:30 PM EDT - 2 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Mar 7, 2024, 8:45 AM EST - 2 years ago

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Mar 4, 2024, 4:30 PM EST - 2 years ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings

Feb 9, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Jan 4, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Dec 15, 2023, 4:10 PM EST - 2 years ago

Edesa Biotech Reports Fiscal Year 2023 Results

Nov 20, 2023, 4:05 PM EST - 2 years ago

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Oct 26, 2023, 4:05 PM EDT - 3 years ago

Edesa Biotech to Present at Dermatology Drug Development Summit

Oct 25, 2023, 9:10 AM EDT - 3 years ago

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug

Oct 12, 2023, 12:15 PM EDT - 3 years ago

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Oct 12, 2023, 12:10 PM EDT - 3 years ago

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Oct 10, 2023, 9:00 AM EDT - 3 years ago

Edesa Biotech Announces One-for-Seven Reverse Share Split

Sep 28, 2023, 8:15 AM EDT - 3 years ago

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

Aug 9, 2023, 4:15 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Jul 26, 2023, 9:00 AM EDT - 3 years ago

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Jun 28, 2023, 7:55 AM EDT - 3 years ago

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Jun 27, 2023, 8:15 AM EDT - 3 years ago

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Jun 15, 2023, 8:00 AM EDT - 3 years ago

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

May 11, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

Apr 20, 2023, 8:30 AM EDT - 3 years ago

Edesa Biotech to Participate in Swiss Biotech Day

Apr 4, 2023, 8:45 AM EDT - 3 years ago

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

Mar 23, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

Mar 16, 2023, 4:10 PM EDT - 3 years ago

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

Mar 15, 2023, 8:10 AM EDT - 3 years ago

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Feb 10, 2023, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Feb 1, 2023, 8:15 AM EST - 3 years ago

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

Boywithathorn Aug. 10 at 5:49 PM

0 · Reply

Beowulfdragonslayer Aug. 10 at 2:22 PM

$EDSA back to $1?

1 · Reply

allemi Aug. 10 at 1:47 PM

$EDSA one day, Boom!!! BP partnership. $25 then $50.

0 · Reply

Treb3k Aug. 9 at 9:40 PM

$EDSA https://hadea.ec.europa.eu/calls-tenders/framework-contracts-speed-development-and-access-next-generation-therapeutics-infectious-diseases_en?

0 · Reply

AllmightyDollah Aug. 9 at 7:23 PM

0 · Reply

Beowulfdragonslayer Aug. 9 at 6:11 PM

$EDSA is the Indian scammer still scammin?

1 · Reply

topstockalerts Aug. 7 at 10:23 PM

$EDSA the market seems to like this one

1 · Reply

Boywithathorn Aug. 7 at 10:03 PM

$EDSA Interesting birds chirping. 🔥

0 · Reply

JoeDomiano Aug. 7 at 9:41 PM

$EDSA

0 · Reply

History101 Aug. 7 at 4:43 PM

$EDSA I was adding all morning...loving it!!

1 · Reply

GaryMelon Aug. 7 at 1:51 AM

$EDSA Truthfully hoping that it stays at these levels for another month. I closed most of my position around $9 and I’m waiting on MLTX and a couple other plays to pan out before I load up again. Happy to be paying what Par did earlier this year.

0 · Reply

Boywithathorn Aug. 6 at 7:47 PM

$EDSA I’m switching massive bullish. I will not knock Par again. He is genius. By winter many of us will be millionaires! Mark this post.

1 · Reply

Boywithathorn Aug. 6 at 5:55 PM

$EDSA

0 · Reply

AllmightyDollah Aug. 6 at 1:28 PM

$EDSA

0 · Reply

Treb3k Aug. 6 at 2:37 AM

$EDSA youre the CEO of this company. you keep throwing millions of your own money in. you move to taking your salary 90% in cash? why? its atypical micro bootech CEO behavior. most of these guys never need the stock to materialize. they dilute and dilute and dilute to pay their salaries. i used to be concerned it was just an ego play. but now its just too much money to be that

1 · Reply

Boywithathorn Aug. 6 at 1:18 AM

$EDSA Why have investors been paying management, directors and 20 employees for the past 3 years?????The company has no trials ongoing and only one drub eb05 is in a BARDA trial which Is Edesa has nothing to do with. THE COMPANY HAS DONE NOTHING!!!!!! The right thing for this scam ass company to do is send all investors 3 years of payment back depending on how many shares we own. It’s beyond insane we are paying these idiots when they DO NOTHING. On top Of that the scammy Indian CEO Pardeep Kumar shorts his company at $20 to $4 in a month and does an offering at $4 and then himself buys half of it. Where is the SEC? Why isn’t Pardeep in jail? This company is beyond insane!!! Anyone from The SEC reading this please investigate this company.

1 · Reply

Boywithathorn Aug. 5 at 8:13 PM

$EDSA

0 · Reply

Boywithathorn Aug. 5 at 7:18 PM

$EDSA doing nothing should be the name of this scam.

0 · Reply

EDSA2Chap11 Aug. 5 at 12:44 PM

$EDSA https://www.canada.ca/en/public-health/news/2026/07/government-of-canada-to-make-an-announcement-regarding-a-new-medical-countermeasures-laboratory-facility-in-winnipeg.html Announcement in less than 3 hours. Paridiprubart is going to be a major constituent of Canadian medical counter measures.

4 · Reply

Treb3k Aug. 4 at 10:16 PM

$EDSA everyone is on vacation

0 · Reply

mapleleafdave Aug. 4 at 3:02 PM

$EDSA

0 · Reply

Boywithathorn Aug. 3 at 10:09 PM

$EDSA

0 · Reply

Market Cap	50.77M
Revenue (ttm)	0.00
Net Income (ttm)	-7.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	17,271
Avg Vol	136,854
Day's Range	N/A - N/A
Shares Out	9.63M
Stochastic %K	58%
Beta	1.08
Analysts	Strong Sell
Price Target	$16.33